The Lung From a Pharmacology Perspective Flashcards
What receptors do drugs that act on the autonomic nervous system to prevent bronchospasm act on?
• is the PNS or SNS dominant? why?
- ß2-adrenergic agonists
- Muscarinic Antagonists
• PNS is dominant in the respiratory tract because it contains receptors that act directly on the bronchial smooth muscle. SNS drugs do not.
What cells do the adrenergic receptors in the lung act on?
- Epithelial Cells
- Mast Cells
- Type II alveolar Cells
M1 Receptors:
• where are they located?
• What do they do?
Location:
• M1 receptors are located on the POST-GANGLIONIC membrane to transduce vagal signal to BOTH:
1. Submucosal Glands
2. Airway Smooth muscle
***M1’s are also responsible for increased glandular secretions in the nasal mucosa
M2 Receptors:
• Where are they located?
• What do they do?
Location:
• M2’s are INHIBITORY Autoreceptors on the PRE-SYNAPTIC membrane of POST-GANGLIONIC FIBERS
• ALSO are found on AIRWAY SMOOTH MUSCLE where they oppose the increase in c-AMP caused by ß2 adrenergic stimulation
M3 Receptors:
• Where are they located?
• What do they do?
Location:
• Bronchial smooth muscle - Bronchoconstriction
•Submucosal Glands - Mucus secretion
What would be the consequence of administering a drug that antagonizes both M2 and M3 receptors?
• Name two drugs that do this.
M2 antagonism:
• tends to enhance PNS effects because there is no off signal with the Ach M2 heteroreceptor
• would help to relax tense bronchi
M3 antagonism:
• tends to attenuate PNS effects because it turns off mucous secretion and smooth muscle contraction
2 drugs:
•Atropine
• Ipratropium
What muscarinic antagonist blocks M1 and M3 receptors equally well?
Tiotropium
What are some 1st generation Antihistamines that may cause drying of secretions in the lungs?
- Chlorpheniramine
- Doxylamine
- Diphenhydramine
What effect would acetylcholinesterase inhibitors have on the lungs? Why?
• Name two.
- Edrophonium
- Neostigmine
=> treat myasthenia gravis
At what stage in the bronchospastic response should SNS drugs be given?
• do these drugs antagonize or agonize receptors?
SNS drugs:
• AGONISTS should be given EARLY in the bronchospastic response otherwise they wont be effective
• Albuterol is the example of such a drug
What is the risk of taking a ß2 agonist?
• May produce bronchoconstriction by increasing the PNS tone
What is the effect of ß2 stimulation on:
• Mast Cells
• Mucociliary Clearance
• Vascular Endothelial Permeability
Mast Cells:
• Reduces Histamine Secretion
Mucociliary Clearance:
• Increase Glycoprotein
• Increase beat frequency of Cilia
Vascular Endothelial Permeability:
• DECREASES Leakage from microvasculature
What is the risk of giving ultra high concentrations of a ß2 agonist?
- CV stimulatory effects
- Prolongation of the QT interval especially in presence of HYPOKALEMIA
- Widening of Pulse Pressure
- DIlation in coronary, pulmonary, and skeletal mm.
How could a ß2 agonist aggravate pre-existing hypokalemia?
- Stimulation of Na+/K+ ATPase in skeletal mm.
- Increased intracellular K+
- Decreased serum K+
*this is why you should avoid giving these with other drugs that cause hypokalemia
What is responsible for the tremor experienced when taking ß2 agonists?
Stimulation of Na+/K+ ATPase activity is responsible for the twitching and tremor seen in people who use these